ProfileGDS5678 / 1451987_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 96% 95% 96% 96% 97% 97% 97% 96% 96% 97% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 18.6335396
GSM967853U87-EV human glioblastoma xenograft - Control 28.9629996
GSM967854U87-EV human glioblastoma xenograft - Control 38.5827695
GSM967855U87-EV human glioblastoma xenograft - Control 48.9948696
GSM967856U87-EV human glioblastoma xenograft - Control 58.8256596
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 18.9451197
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.0556497
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.0961497
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 48.9723696
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 18.7972196
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.1570197
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 38.7734196
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 48.8072796
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 58.9604596